Physician profile
Peter H Hwang
NPI 1629127428
$90,164.26
in general payments reported to CMS, 2019-2025
11 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $6,641 · 2021: $30.73 · 2022: $14K · 2023: $6,219 · 2024: $5,395 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $584 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $91.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,386.64 |
| Food and Beverage | $583.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $91.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $58,884.68 | 2019-2025 | Clarifix Cryotherapy Device, Scopis Ent, Hemopore |
| Glaxosmithkline, LLC. | $13,901.64 | 2022-2023 | Nucala |
| Genzyme Corporation | $10,449.35 | 2019-2020 | |
| Medtronic, INC. | $6,554.95 | 2023-2025 | Propel, Stealthstation S8 Platform |
| Integra Lifesciences Corporation | $224.90 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Smith+Nephew, INC. | $70.96 | 2019 | |
| Aerin Medical INC. | $29.23 | 2019 | |
| Medtronic USA, INC. | $28.69 | 2019 | |
| Neurent Medical Limited | $19.86 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$19,968.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.